glp 1 science Companies seek a second obesity treatment revolution—in pill form | Examining Alternative Effects of GLP-1

Globally, the GLP-1 receptor agonist market is projected to grow at a CAGR of 17.4% from 2025 to 2030, when it could reach an eye-watering value of 132bn (Grand View Research)

Hypothalamic tanycytes-masters and servants of metabolic, neuroendocrine, and neurogenic functions

Dosage calculators for precise dosing Accurate dosing is a prerequisite for meaningful timing optimization

Adv Health Mater

Mozaffarian took time to answer questions about the new clinical advisory and how individuals and clinicians can integrate nutrition and lifestyle interventions into GLP-1 treatment to increase their chances for success

It's a long-term commitment, not a quick fix